Fig. 4From: Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancerHMGB1 promoted the migration, invasion and drug resistance of A549 cells and A549-DDP cells. (a) Transwell assay was conducted to determine the effects of HMGB1 on the migration ability of A549 cells and A549-DDP cells. Magnification, ×200. (b) Transwell assay was conducted to detect the effect of HMGB1 on the invasive ability of A549 cells and A549-DDP cells. Magnification, ×200. (c-d) Western blot was performed to detect the expression levels of LRP, MRP, P-gp, Caspase, Bax and Bcl-2 in A549 cells and A549-DDP cells under cisplatin and paclitaxel treatment, respectively. *P < 0.05, **P < 0.01 and ***P < 0.001Back to article page